复星医药

- 600196

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
复星医药(600196) 利润表
单位:万元
报表日期2013-12-312013-09-302013-06-302013-03-31
一、营业总收入999,640.90707,078.09450,928.94205,658.60
营业收入999,640.90707,078.09450,928.94205,658.60
二、营业总成本934,856.59662,484.09423,855.41192,773.65
营业成本554,336.90395,763.19251,425.13114,259.64
营业税金及附加7,492.235,335.413,565.061,790.29
销售费用184,353.38136,513.1388,568.5940,580.24
管理费用142,063.8395,327.0760,504.2827,608.41
财务费用38,354.0128,439.0118,824.908,493.72
研发费用--------
资产减值损失8,256.251,106.30967.4541.35
公允价值变动收益3,037.013,951.174,006.073,265.17
投资收益214,062.01138,339.98109,339.6127,520.00
其中:对联营企业和合营企业的投资收益77,169.6758,166.8538,023.4119,369.50
汇兑收益--------
三、营业利润281,883.32186,885.16140,419.2043,670.11
加:营业外收入10,436.387,225.775,286.901,703.04
减:营业外支出1,692.48723.19597.1092.71
其中:非流动资产处置损失1,045.5097.9971.970.46
四、利润总额290,627.22193,387.74145,108.9945,280.45
减:所得税费用50,632.4131,320.6724,893.864,030.68
五、净利润239,994.81162,067.08120,215.1341,249.78
归属于母公司所有者的净利润202,705.77138,907.96105,314.1235,200.73
少数股东损益37,289.0423,159.1114,901.016,049.05
六、每股收益
基本每股收益(元/股)0.90000.62000.47000.1600
稀释每股收益(元/股)0.90000.62000.47000.1600
七、其他综合收益39,522.9628,525.254,703.872,544.98
八、综合收益总额279,517.77190,592.33124,919.0143,794.76
归属于母公司所有者的综合收益总额242,630.22167,640.44110,693.3738,089.41
归属于少数股东的综合收益总额36,887.5522,951.8914,225.635,705.35
下载全部历史数据到excel中 返回页顶